Shopping Cart 0
Cart Subtotal
USD 0

Celltrion Inc (068270) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Celltrion Inc (068270)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Celltrion Inc (Celltrion) is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, psoriatic arthritis and psoriasis. Its pipeline portfolio spans monoclonal antibody biosmilars for the treatment of rheumatoid arthritis; colorectal cancer; and respiratory disease; and antibody biologics for and vaccines for infectious diseases such as hepatitis B, influenza, rabies, breast cancer and seasonal influenza. Celltrion develops drugs by utilizing its bioengineering and mammalian cell-culture technology. The company also carries out contract manufacturing of biosimilars. It has operational presence in Korea, Russia, the UK, and the US. Celltrion is headquartered in Incheon city, South Korea.

Celltrion Inc Key Recent Developments

Oct 23,2018: Celltrion Healthcare organizes forum with patient interest groups to provide information on the use of biosimilar drugs in oncology

Oct 04,2018: Celltrion to Complete Expansion in Incheon, South Korea Facility

Sep 25,2018: FDA Issues Form 483 to Celltrion Inc

Sep 18,2018: Celltrion receives EIR from the FDA

Jun 26,2018: Celltrion to Launch Bio CDMO in Incheon, South Korea

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Celltrion Inc-Key Facts

Celltrion Inc-Key Employees

Celltrion Inc-Key Employee Biographies

Celltrion Inc-Major Products and Services

Celltrion Inc-History

Celltrion Inc-Company Statement

Celltrion Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Celltrion Inc-Business Description

Business Segment: Biopharmaceuticals

Overview

Performance

Business Segment: Chemical Medicines

Overview

Performance

Business Segment: Other

Overview

Performance

R&D Overview

Celltrion Inc-SWOT Analysis

SWOT Analysis-Overview

Celltrion Inc-Strengths

Celltrion Inc-Weaknesses

Celltrion Inc-Opportunities

Celltrion Inc-Threats

Celltrion Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Celltrion Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Oct 23, 2018: Celltrion Healthcare organizes forum with patient interest groups to provide information on the use of biosimilar drugs in oncology

Oct 04, 2018: Celltrion to Complete Expansion in Incheon, South Korea Facility

Sep 25, 2018: FDA Issues Form 483 to Celltrion Inc

Sep 18, 2018: Celltrion receives EIR from the FDA

Jun 26, 2018: Celltrion to Launch Bio CDMO in Incheon, South Korea

Jun 05, 2018: Celltrion Launches Bio CDMO Business for the Development of New Drugs

May 16, 2018: FDA Issues Complete Response Letters to Celltrion for Two Biosimlars

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Celltrion Inc, Performance Chart (2014-2018)

Celltrion Inc, Ratio Charts

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Celltrion Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Celltrion Inc, Key Facts

Celltrion Inc, Key Employees

Celltrion Inc, Key Employee Biographies

Celltrion Inc, Major Products and Services

Celltrion Inc, History

Celltrion Inc, Subsidiaries

Celltrion Inc, Key Competitors

Celltrion Inc, Ratios based on current share price

Celltrion Inc, Annual Ratios

Celltrion Inc, Annual Ratios (Cont...1)

Celltrion Inc, Annual Ratios (Cont...2)

Celltrion Inc, Interim Ratios

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Celltrion Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Celltrion Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

ViroMed Co Ltd

Peptron Inc

JW Pharmaceutical Corp

Genexine Inc

ChoongAng Vaccine Laboratory

Biosolution Co Ltd

Alvogen Korea Co Ltd

Advanced Protein Technologies Corp

Celltrion Inc (068270)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Celltrion Inc (Celltrion) is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, psoriatic arthritis and psoriasis. Its pipeline portfolio spans monoclonal antibody biosmilars for the treatment of rheumatoid arthritis; colorectal cancer; and respiratory disease; and antibody biologics for and vaccines for infectious diseases such as hepatitis B, influenza, rabies, breast cancer and seasonal influenza. Celltrion develops drugs by utilizing its bioengineering and mammalian cell-culture technology. The company also carries out contract manufacturing of biosimilars. It has operational presence in Korea, Russia, the UK, and the US. Celltrion is headquartered in Incheon city, South Korea.

Celltrion Inc Key Recent Developments

Oct 23,2018: Celltrion Healthcare organizes forum with patient interest groups to provide information on the use of biosimilar drugs in oncology

Oct 04,2018: Celltrion to Complete Expansion in Incheon, South Korea Facility

Sep 25,2018: FDA Issues Form 483 to Celltrion Inc

Sep 18,2018: Celltrion receives EIR from the FDA

Jun 26,2018: Celltrion to Launch Bio CDMO in Incheon, South Korea

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Celltrion Inc-Key Facts

Celltrion Inc-Key Employees

Celltrion Inc-Key Employee Biographies

Celltrion Inc-Major Products and Services

Celltrion Inc-History

Celltrion Inc-Company Statement

Celltrion Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Celltrion Inc-Business Description

Business Segment: Biopharmaceuticals

Overview

Performance

Business Segment: Chemical Medicines

Overview

Performance

Business Segment: Other

Overview

Performance

R&D Overview

Celltrion Inc-SWOT Analysis

SWOT Analysis-Overview

Celltrion Inc-Strengths

Celltrion Inc-Weaknesses

Celltrion Inc-Opportunities

Celltrion Inc-Threats

Celltrion Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Celltrion Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Oct 23, 2018: Celltrion Healthcare organizes forum with patient interest groups to provide information on the use of biosimilar drugs in oncology

Oct 04, 2018: Celltrion to Complete Expansion in Incheon, South Korea Facility

Sep 25, 2018: FDA Issues Form 483 to Celltrion Inc

Sep 18, 2018: Celltrion receives EIR from the FDA

Jun 26, 2018: Celltrion to Launch Bio CDMO in Incheon, South Korea

Jun 05, 2018: Celltrion Launches Bio CDMO Business for the Development of New Drugs

May 16, 2018: FDA Issues Complete Response Letters to Celltrion for Two Biosimlars

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Celltrion Inc, Performance Chart (2014-2018)

Celltrion Inc, Ratio Charts

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Celltrion Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Celltrion Inc, Key Facts

Celltrion Inc, Key Employees

Celltrion Inc, Key Employee Biographies

Celltrion Inc, Major Products and Services

Celltrion Inc, History

Celltrion Inc, Subsidiaries

Celltrion Inc, Key Competitors

Celltrion Inc, Ratios based on current share price

Celltrion Inc, Annual Ratios

Celltrion Inc, Annual Ratios (Cont...1)

Celltrion Inc, Annual Ratios (Cont...2)

Celltrion Inc, Interim Ratios

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Celltrion Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Celltrion Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

ViroMed Co Ltd

Peptron Inc

JW Pharmaceutical Corp

Genexine Inc

ChoongAng Vaccine Laboratory

Biosolution Co Ltd

Alvogen Korea Co Ltd

Advanced Protein Technologies Corp

chat_bubbleLet's Chat